196 related articles for article (PubMed ID: 34930277)
21. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
22. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance.
Chung KY; Quek JM; Neo SH; Too HP
J Mol Diagn; 2020 May; 22(5):610-618. PubMed ID: 32151712
[TBL] [Abstract][Full Text] [Related]
23. A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer.
Zhang Y; Roth JA; Yu H; Ye Y; Xie K; Zhao H; Chang DW; Huang M; Li H; Qu J; Wu X
Carcinogenesis; 2019 Jul; 40(5):643-650. PubMed ID: 30428030
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
[TBL] [Abstract][Full Text] [Related]
25. A novel microRNA signature for the detection of melanoma by liquid biopsy.
Sabato C; Noviello TMR; Covre A; Coral S; Caruso FP; Besharat ZM; Splendiani E; Masuelli L; Battistelli C; Vacca A; Catanzaro G; Po A; Anichini A; Maio M; Ceccarelli M; Di Giacomo AM; Ferretti E
J Transl Med; 2022 Oct; 20(1):469. PubMed ID: 36243798
[TBL] [Abstract][Full Text] [Related]
26. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
27. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
28. Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes.
Lee HM; Wong WKK; Fan B; Lau ES; Hou Y; O CK; Luk AOY; Chow EYK; Ma RCW; Chan JCN; Kong APS
Sci Rep; 2021 Dec; 11(1):23756. PubMed ID: 34887498
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
[TBL] [Abstract][Full Text] [Related]
30. Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer.
Yan C; Hu J; Yang Y; Hu H; Zhou D; Ma M; Xu N
Mol Med Rep; 2019 Nov; 20(5):3991-4002. PubMed ID: 31545424
[TBL] [Abstract][Full Text] [Related]
31. A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
Nadal E; Truini A; Nakata A; Lin J; Reddy RM; Chang AC; Ramnath N; Gotoh N; Beer DG; Chen G
Sci Rep; 2015 Jul; 5():12464. PubMed ID: 26202143
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNAs as potential biomarkers for coronary plaque rupture.
Li S; Lee C; Song J; Lu C; Liu J; Cui Y; Liang H; Cao C; Zhang F; Chen H
Oncotarget; 2017 Jul; 8(29):48145-48156. PubMed ID: 28624816
[TBL] [Abstract][Full Text] [Related]
33. Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis.
Nziza N; Jeziorski E; Delpont M; Cren M; Chevassus H; Carbasse A; Mahe P; Abassi H; Joly-Monrigal P; Schordan E; Mangé A; Jorgensen C; Apparailly F; Duroux-Richard I
Cells; 2019 Nov; 8(12):. PubMed ID: 31779271
[TBL] [Abstract][Full Text] [Related]
34. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
35. A novel combination of serum microRNAs for the detection of early gastric cancer.
Abe S; Matsuzaki J; Sudo K; Oda I; Katai H; Kato K; Takizawa S; Sakamoto H; Takeshita F; Niida S; Saito Y; Ochiya T
Gastric Cancer; 2021 Jul; 24(4):835-843. PubMed ID: 33743111
[TBL] [Abstract][Full Text] [Related]
36. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
37. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
[TBL] [Abstract][Full Text] [Related]
38. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
40. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]